Seattle shellfish test positive for this drug

[Casey Research] Editor's Note: Over a 10-year period, Chris Mayer's stock picks outperformed billionaire investors including Carl Icahn and David Einhorn. And now he's just discovered a small company that could solve a national emergency and disrupt an entire multi-billion dollar industry. Please read this urgent message before it's too late... --------------------------------------------------------------- Dear Reader, In another shocking milestone... The opioid epidemic is now affecting marine life in Seattle. For the first time, scientists who monitor pollution have detected traces of oxycodone in the mussels of Puget Sound. In short, people in greater Seattle are consuming so many opioids that it's contaminating the wastewater and draining into the sound. A new study estimates the opioid crisis has cost Washington state $34 billion over four years. - Nationwide, the economic cost of the crisis was estimated to be $504 billion in 2015 alone. - More than 300,000 Americans have died from opioid-related overdoses since 2000. - In 2016, more than 2 million Americans had an addiction to prescription or illicit opioids. [No wonder President Trump calls the opioid crisis a "national shame" and has mobilized his entire Administration to battle it by declaring it a National Emergency.]( Now a company I discovered is joining the battle to fight this killer. And they already have [FDA-approval on a new medication to treat this epidemic](. A 25-year pharmaceutical veteran and current CEO had this to say about it: "This new technology has the potential to greatly influence the way patients are treated today." And the co-director of opioid research at Brandeis University said, "It's potentially a game changer... This could become the first-line [medication] for opioid addiction." Simply put, [I believe this new drug could become the premier player in the opioid treatment world...]( And turn into a multi-billion-dollar medication in just a few years. When companies in the medical sector solve a big health problem, they show investors life-changing gains. - Amgen returned 163,200% - Biogen returned 95,800% - Valeant Pharmaceuticals returned 81,500% - Abbott Labs returned 196,500% - Forest Laboratories returned 787,400% Could this new company be the next to ride this unique wave? [Click here to get all the details before it's too late.]( Sincerely, Chris Mayer Editor, Focus © Casey Research LLC. All Rights Reserved. 455 NE 5th Ave, Suite D317, Delray Beach, FL 33483 No longer wish to receive special offers from us? [Click here for options.](